Where are clinical trials going? Society and clinical trials

Journal of Internal Medicine

Volumn 255, Issue 2, 2004, Pages 151-158

  Sleight, P ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Conflict of interest; Data and safety monitoring; Fraud; Health economics; Randomization bias; Trial ethics

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; CARDIOVASCULAR AGENT; DIURETIC AGENT; DUTEPLASE; FIBRINOLYTIC AGENT; HORMONE; MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE; STREPTOKINASE; STREPTOMYCIN; TISSUE PLASMINOGEN ACTIVATOR;

ADVERTIZING; BLEEDING; BRAIN HEMORRHAGE; CANCER; CANCER THERAPY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMMERCIAL PHENOMENA; DATA ANALYSIS; DRUG EFFICACY; DRUG INDUSTRY; EATING; ELECTROCARDIOGRAM; ETHICS; FINANCIAL MANAGEMENT; FOLLOW UP; HEALTH CARE ORGANIZATION; HEALTH SERVICE; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; INFORMED CONSENT; LUNG TUBERCULOSIS; MEASLES; MEDICAL INFORMATION; MENOPAUSAL SYNDROME; MORTALITY; MUMPS; OUTCOMES RESEARCH; POLITICS; PRESCRIPTION; PRIORITY JOURNAL; PROFIT; PUBLIC OPINION; REVIEW; RISK BENEFIT ANALYSIS; RUBELLA; SAFETY; SEVERE ACUTE RESPIRATORY SYNDROME; ST SEGMENT ELEVATION; UNIVERSITY;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

CLINICAL TRIALS; CONFLICT OF INTEREST; HUMANS; PUBLIC OPINION; RESEARCH SUPPORT; SCIENTIFIC MISCONDUCT;

EID: 1242317786     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01294.x     Document Type: Review

References (29)

1. Yusuf S, Collins R, Peto R. Why do we need some large, simple randomised trials? Stat Med 1984; 3: 409-20.
2. Herrington DM, Vittinghoff E, Lin F et al. for the HERS Study Group. Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/progestin Replacement Study (HERS). Circulation 2002; 105: 2962-7.
3. Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002; 288: 321-33.
4. Collins R, Peto R, Gray R, Parish S. Large-scale randomised evidence: trials and overviews. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine, 3rd edn. Oxford: Oxford University Press, 1996; 21-32.
5. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000; 355: 1757-70.
6. ISIS-2 (Second International Study of Infarct Survival) Trial Study Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; II: 349-60.
7. GISSI (Gruppo Italiano per lo Studie della Streptochinasi nell'Infarto miocardico) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; I: 397-401.
8. ISIS-3 Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41299 cases of suspected acute myocardial infarction. Lancet 1992; 339: 753-70.
9. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
10. Edwards SJL, Lilford RJ, Braunholtz DA, Jackson JC, Hewison J, Thornton J. Ethics of randomised trials. In: Brazier J, Fitzpatrick R, Reeves B, eds. Health Services Research Methods: A Guide to Best Practice. London: BMJ, 1998: 98-107.
11. The Swedish Medical Research Council's Board for Ethics in Research. Guidelines for Ethical Evaluation of Medical Research Involving Human Research Subjects. The Policy and Organization of Research Ethics in Sweden. Stockholm: The Swedish Medical Research Council, 1996/1999. ISSN: 1401288X. ISBN: 91-85547-13-1.
12. Drazen JM. Institutions, contracts, and academic freedom. N Engl J Med 2002; 347: 1362-3.
13. Holden C. NEJM admits breaking its own tough rules. Science 2000; 287: 1573.
14. Engler RL. Editorial. Conflicts of interest. Q J Med 2002; 95: 713-5.
15. Schulman KA, Seils DM, Timbie JW et al. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med 2002; 347: 1335-41.
16. Weatherall D. Academia and industry: increasingly uneasy bedfellows. Lancet 2000; 355: 1574.
17. Nathan DG, Weatherall DJ. Academic freedom in clinical research. N Engl J Med 2002; 347: 1368-71.
18. Collins R, Peto R, Baigent C, Sleight P. Aspirin, heparin and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 1997; 336: 847-60.
19. Dundar Y, Hill R, Dickson R, Walley T. Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review. Q J Med 2003; 96: 103-13.
20. Lenzer J. Controversial stroke trial is under review following BMJ report. BMJ 2002; 325: 1131.
21. Sleight P. Data-monitoring committees in clinical trials. Lancet 1993; 341: 1219-20.
22. Boers M. Seminal pharmaceutical trials: maintaining masking in analysis. Lancet 2002; 360: 100-1.
23. Tu K, Mamdani MM, Jacka RM, Forde NJ, Rothwell DM, Tu JV. The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario. Can Med Assoc J 2003; 168: 553-7.
24. Hampton JR. Clinical trial safety committees: the devil's spoon. BMJ 2000; 320: 244-5.
25. Farthing M, Lock S, Wells F (eds). Fraud and Misconduct in Biomedical Research. LondonBMJ Books, 2001.
26. Lock SP. Lessons from the Pearce affair: handling scientific fraud. Belatedly, Britain should abandon its lax approach to scientific fraud. BMJ 1995; 310: 1547-8.
27. Sheldon T. Dutch neurologist found guilty of fraud after falsifying 438 case records. BMJ 2002; 325: 734.
28. Moses H, Braunwald E, Martin JB, Thier SO. Collaborating with industry - choices for the academic medical center. N Engl J Med 2002; 347: 1371-5.
29. Hargreaves S. Wellcome Trust promotes ethical research in developing world. BMJ 2002; 325: 986.